Highlight: A Potential Breakthrough in Combatting Alzheimer's
Jul 10, 2023•13 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
This week, the FDA fully approved a new drug meant to combat the effects of Alzheimer's disease. Whom will this ultimately benefit? Jearlyn asks Sue Parriott, CEO of the Minnesota-North Dakota chapter of the Alzheimer's Association.
For the best experience, listen in Metacast app for iOS or Android